Attention Lumen Technologies Inc. Investors: Don’t Miss Out on Your Chance to Secure Counsel Before the Deadline! (And No, We’re Not Talking About a Therapy Session)

Welcome to the Blog Post! November 04, 2023 Hey there fellow investors! Have you heard the latest news about Rosen Law Firm reminding purchasers of securities of Lumen Technologies, Inc.? If not, don’t worry, I’ve got you covered. So, let’s dive into what’s been going on with LUMN stock between March 11, 2019 and July…

Read More

Rosen, a Trusted Firm, Urges DLocal Limited Investors to Seek Counsel Before Securities Class Action Deadline

ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages DLocal Limited Investors to Secure Counsel Before Important Deadline in Securities Class Action – DLO NEW YORK, Nov. 04, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of DLocal Limited (NASDAQ: DLO) between May 2, 2022 and May…

Read More

Get Ready to Drop it Like it’s Hot: Treasury Yields Take a Dive in Biggest Weekly Plunge Since Last Year’s Thanksgiving and March Madness!

Market Extra: 10- and 30-year Treasury yields head for biggest weekly drops since last November and March 2020 The Latest Trends in the Bond Market Long-term U.S. Treasury yields are currently on track for their largest weekly declines since March 2020 and last November. This surprising development comes just a mere two weeks after these…

Read More

Take Action: GigaCloud Shareholder Losses? Contact Faruqi & Faruqi Securities Litigation Partner, James Josh Wilson for Support

Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson If you purchased or acquired (i) GigaCloud Class A ordinary shares pursuant and/or traceable to the registration statement and prospectus issued in connection with the Company’s August 2022 initial public offering (“IPO” or the “Offering”); and/or (ii) GigaCloud securities, you may have legal rights. Faruqi &…

Read More

Unleashing the Power of ENLIGHTEN: Candel Therapeutics Shares Exciting Preclinical Findings at SITC Conference!

Heading 1 Heading 2 Heading 3 The first experimental agent from the enLIGHTEN™ Discovery Platform is Alpha-201-macro1, an investigational viral immunotherapy designed to activate innate immune surveillance. This groundbreaking development in the field of medicine has the potential to revolutionize the way we approach treatment for various diseases. By harnessing the power of the immune…

Read More

Reminder for KenVue Shareholders: Contact Faruqi & Faruqi Securities Litigation Partner James Josh Wilson for Losses Discussion

Reminder for KenVue Shareholders: Contact Faruqi & Faruqi Securities Litigation Partner James Josh Wilson for Losses Discussion Description: James (Josh) Wilson Faruqi & Faruqi LLP Faruqi & Faruqi Securities Litigation Partner James (Josh) Wilson If you purchased or acquired securities in Kenvue securities pursuant and/or traceable to the registration statement and related prospectus (collectively, the…

Read More